In-house Axiom GeneTitan · Illumina via Partner Lab · Human, Plant & Animal Arrays

Dense, reproducible genotyping at population scale.

Genome-wide association studies, marker-assisted selection, genetic diversity panels, and quality-control genotyping all need dense, reproducible, cost-effective SNP data. Arrays deliver exactly that: fixed marker sets, >99% call rates, and per-sample economics that sequencing cannot match at scale.

Axiom GeneTitan
in-house · Illumina via partner lab
Custom arrays
from 1,500 to 2.6M markers
Human, plant & animal
catalog arrays
Full GWAS
analysis pipeline

SNP Genotyping at Nucleome Informatics

Nucleome Informatics offers SNP genotyping with Thermo Fisher Axiom arrays run in-house on our GeneTitan MC and Illumina Infinium arrays processed on the iScan through our partner laboratory — with study design, QC and analysis from raw calls to GWAS results by our team, for human, plant and animal studies.

Every project includes:

  • Genotype calls (call rate, per-SNP and per-sample QC metrics) in standard formats (PLINK, VCF, Axiom/Illumina reports)
  • Full QC pipeline: sample call rate, SNP call rate, heterozygosity, sex concordance, relatedness/duplicates, Hardy–Weinberg screening
  • Population structure analysis (PCA, ADMIXTURE-style clustering)
  • Complete GWAS analysis: association testing, Manhattan/QQ plots, multiple-testing correction, annotation of significant loci
  • Imputation to reference panels (TOPMed, HRC/1000 Genomes for human; species-appropriate panels elsewhere)

Custom array development

  • Axiom myDesign: submit your SNPs (from sequencing, WGS, or databases); Thermo Fisher's design pipeline selects and places markers from 1,500 (384HT format, minimum order 1,920 samples) up to 2.6 million markers (GW plate formats, minimum 480 samples). Design turnaround is typically as few as 6 weeks after SNP lockdown.
  • Population-optimised GWAS modules: imputation-based SNP selection enriches the array with markers informative for your population — critical for Indian and South Asian cohorts under-represented in global arrays.
  • Multi-species support: custom arrays for any organism with sequence data — crops, livestock, fish, pathogens, and wildlife.

Major human arrays, two platforms

Nine human genotyping arrays: seven Axiom arrays run in-house on our GeneTitan MC, and two Illumina arrays run through our partner laboratory. Drag any array into the circle — or tap it — to see its markers, content and the studies it suits.

Thermo Fisher Axiom · in-houseOur own GeneTitan MC · 96- and 384-array plates · automated hybridisation, wash and scan
Illumina Infinium · partner labProcessed on the iScan by our partner laboratory · 24 samples per BeadChip · QC and analysis by Nucleome
Axiom · in-house
Illumina · partner lab
Drop an array hereDrag any array into the circle, or tap it
⟳

Pick an array to explore

Nine human genotyping arrays sit on the wheel — seven Axiom arrays run in-house on our GeneTitan MC and two Illumina arrays run through our partner lab. Drop one into the centre to see its markers, content and the studies it suits.

Best for
Key content
    See all nine arrays as a list
    In-house

    Axiom human arrays (in-house GeneTitan)

    Axiom PangenomiX

    >900,000 markers
    Multi-ancestry GWASBiobanks & PRSPGx research
    • ~800,000-marker imputation module across five ancestries (African, admixed American, East Asian, South Asian, European)
    • ACMG 73 and ClinVar pathogenic variants genotyped directly
    • NHGRI-EBI GWAS Catalog, CPIC, PharmGKB and PharmaADME content
    • HLA typing for 11 MHC Class I and II loci
    • Fixed-region and genome-wide CNV analysis
    • Disease modules: Alzheimer's, cancer, cardiometabolic, diabetes, neurological
    • From as little as 100 ng DNA

    Axiom PangenomiX Plus

    >900,000 markers
    Deep pharmacogenomicsDrug response
    • All PangenomiX content
    • Genotypes markers in difficult regions such as the pharmacogene CYP2D6
    • Over 80 critical star alleles in CYP1A2, CYP2D6, CYP2B6, CYP2A6, CYP2C19, CYP2C8 and SULT1A1 when run with the Axiom 2.0 Plus assay
    • Pharmacogenomic translation reports with metabolizer status

    Axiom Asia PMRA

    >750,000 markers
    Indian & South Asian cohortsEast Asian cohorts
    • Imputation grid of >540,000 markers optimised for South and East Asian populations, including 1–5% allele frequencies
    • >23,400 NHGRI-EBI GWAS Catalog markers; >9,200 ACMG markers
    • PGx and ADME content (CPIC, PharmGKB)
    • HLA, KIR and autoimmune markers; disease modules
    • Up to 50,000 custom markers without affecting imputation

    Axiom Precision Medicine Research Array (PMRA)

    >900,000 markers
    Precision medicineCommon & rare disease
    • Genome-wide imputation grid of ~800,000 markers
    • >23,000 ClinVar and >9,000 ACMG markers; >15,000 GWAS Catalog markers
    • >33,000 loss-of-function markers
    • PGx variants per CPIC guidelines and star alleles
    • Cancer, immune and blood-phenotype variants
    • Fingerprint markers for sample tracking

    Axiom Precision Medicine Diversity Array (PMDA)

    >900,000 markers
    Highly diverse cohortsBiobanking
    • High-coverage GWAS grid for diverse populations
    • ACMG 59 and ClinVar clinical research content
    • PGx and ADME markers with star-allele translation tables
    • Rare blood typing and bleeding-disorder variants
    • >2,000 markers for ancestry (Y, mitochondrial), lifestyle and traits

    UK Biobank Axiom Array

    >800,000 markers
    European-ancestry GWASLarge biobanks
    • >600,000-marker GWAS grid optimised for European populations
    • >9,000 ACMG and >8,000 GWAS Catalog markers
    • Rare coding, HLA, KIR and blood-phenotype variants
    • Used to genotype ~450,000 of the ~500,000 UK Biobank participants

    Axiom myDesign Custom Arrays

    1,500 – 2.6M markers
    Indian enrichmentFine-mappingAny species
    • Choose from more than 13 million genotype-tested markers in the Axiom Genomic Database, or submit your own
    • Combine GWAS grids, ClinVar/ACMG, PGx, HLA, CNV and custom variants
    • Designs in as few as 6 weeks after SNP lockdown
    • 96- and 384-array formats (minimum orders apply)
    Partner lab

    Illumina Infinium human arrays (via partner lab)

    Infinium Global Screening Array-24 v3.0 (GSA)

    654,027 fixed markers
    Population-scale cohortsCost-efficient GWAS
    • Multi-ethnic genome-wide content with high imputation performance across 26 populations
    • Clinical research content from ClinVar, NHGRI, PharmGKB and ExAC, including PGx and newborn/carrier screening research markers
    • ~2,900 ancestry-informative markers and QC markers
    • Up to 100,000 custom markers; 24 samples per BeadChip; 200 ng DNA

    GSA + Multi-Disease (GSA-MD)

    ~700,000 markers
    Disease-focused cohortsCase–control studies
    • Full GSA v3.0 content
    • Plus the consortium multi-disease booster of ~50,000 markers
    • Same iScan workflow and analysis pipeline as GSA

    Which array for which study?

    Your studyRecommended arrayWhy
    Indian or South Asian cohortAxiom Asia PMRA, or a myDesign array with Indian enrichmentImputation grid built for South and East Asian variation
    Multi-ancestry biobank or PRSAxiom PangenomiX or PMDAImputation across five ancestries plus clinical research content
    Pharmacogenomics or drug responseAxiom PangenomiX PlusCYP2D6 and other difficult genes, star alleles and metabolizer reports
    European-ancestry cohortUK Biobank Axiom ArrayGrid optimised for European populations; comparable with UK Biobank data
    Large, budget-sensitive GWASIllumina GSA v3.0Widely used, economical per sample, strong imputation
    Disease case–control studyGSA-MD or Axiom PMRAExtra disease-associated content on top of the GWAS grid
    Novel population, crop or animalAxiom myDesign custom arrayMarkers chosen from your own data, 1,500 to 2.6 million
    Figure A Total markers per catalog array.
    Axiom PangenomiX / PlusAxiom PMRAAxiom PMDAUK Biobank AxiomAxiom Asia PMRAIllumina GSA v3.0 >900K>900K>900K>800K>750K654K + up to 100K custom 0300K600K900K Axiom (in-house)Illumina (partner lab)Custom add-on capacity
    Figure A | Marker counts as published by the manufacturers. Axiom myDesign custom arrays range from 1,500 to 2.6 million markers.

    Marker counts are as published by Thermo Fisher Scientific and Illumina for current catalog versions. The arrays are labelled For Research Use Only by their manufacturers. Axiom arrays are processed in-house on our GeneTitan MC; Illumina arrays are processed by our partner laboratory, with study design and analysis by Nucleome.

    Crops, livestock and aquaculture, on one wheel

    Axiom agrigenomics arrays, all run in-house on our GeneTitan MC. Drag any array into the circle — or tap it — to see its markers and what it is used for.

    Crops · Custom
    Animals · Fish
    Drop an array hereDrag any array into the circle, or tap it
    ⟳

    Pick an array to explore

    Eleven Axiom agrigenomics arrays sit on the wheel — crops and custom designs at the top, livestock, poultry and aquaculture below.

    Used for
    Key facts
      See all eleven arrays as a table
      ArraySpeciesMarkersTypical use
      Axiom Rice Genotyping ArrayRice49,600Diversity, mapping and GWAS
      Axiom Wheat Breeders' ArrayHexaploid bread wheat35,143Genotyping elite breeding lines
      Axiom Maize Genotyping ArrayMaize616,201High-density GWAS and mapping
      Axiom Peanut Array (Arachis2)Groundnut / peanut47,837Trait mapping and molecular breeding
      Axiom myDesign (agrigenomics)Any plant or animal1,500 – 2.6 millionCustom designs, any ploidy, multiple species
      Axiom Genome-Wide BOS 1 BovineCattle (Bos taurus and Bos indicus)648,855Genomic selection and GWAS, including Zebu breeds
      Axiom Buffalo Genotyping ArrayWater buffalo90,000Breeding, research and conservation
      Axiom Goat v1Goat58,655Breeding and diversity
      Axiom Ovine (51K)Sheep51,000Breeding and diversity
      Axiom Genome-Wide Chicken (600K)Chicken (broilers and layers)580,961Genomic selection, GWAS and mapping
      Axiom Shrimp & TilapiaShrimp and tilapia67,339Aquaculture breeding

      Marker counts are as published by Thermo Fisher Scientific and in the array development papers. Other Axiom catalog arrays — including porcine (HD and breeders), equine, canine, turkey, trout, eucalyptus, pear, strawberry, citrus and high-density wheat — are available on request. Agrigenomics arrays are labelled For Research Use Only.

      From first principles to expert-level analysis

      New here? Start with Foundations. Planning a study or reviewing results? Jump to Practitioner or Expert. Each level builds on the one before it, so you can read this page as a short course or dip in where you need to.

      Start here if you are new to this service — six ideas that explain what it is and why it matters.

      LEVEL 1

      What is SNP genotyping?

      Reading the identity of single-letter variants (SNPs) at thousands to millions of positions across the genome — a fixed, reproducible snapshot of genetic variation.

      LEVEL 1

      Why use arrays instead of sequencing?

      Arrays are cheaper per sample at fixed marker sets, produce highly reproducible calls, and are simpler to analyse. Sequencing discovers new variants; arrays type known ones at scale. Large GWAS and breeding programmes overwhelmingly use arrays.

      LEVEL 1

      What is a GWAS?

      A genome-wide association study: testing each SNP for statistical association with a trait (disease, yield, milk production, growth) across hundreds or thousands of individuals.

      LEVEL 1

      What is a custom array?

      An array designed for your project: you provide SNPs (from your own sequencing data or databases), and the manufacturer places them on a purpose-built array. Axiom myDesign supports 1,500–2.6M markers.

      LEVEL 1

      Which species are supported?

      Human, plus a wide range of plants and animals through catalog arrays, and essentially any organism with sequence data through custom design.

      LEVEL 1

      What do I get?

      Genotype calls, QC reports, population structure analysis, and — for GWAS projects — association results with publication-ready figures.

      For scientists planning a project or reading a report: how each step works and how it can mislead.

      LEVEL 2

      Platform selection

      Axiom excels at agrigenomics throughput and flexible custom design; Illumina's GSA dominates human cohort genotyping with strong imputation support. We recommend based on species, sample number, and marker requirements. Axiom arrays run in-house; Illumina arrays run through our partner lab.

      LEVEL 2

      Array design (custom projects)

      You supply SNPs; the design pipeline scores each marker for convertibility and places the best set. Axiom design typically completes in as few as 6 weeks after SNP lockdown. We manage the design submission and review convertibility reports with you.

      LEVEL 2

      Laboratory workflow

      DNA is whole-genome amplified, fragmented, hybridised to the array, and stained/imaged (in-house on our GeneTitan for Axiom; on the iScan at our partner lab for Infinium). Automated calling produces genotype calls with per-marker quality scores.

      LEVEL 2

      Quality control

      Standard GWAS QC filters: sample call rate (typically ≥98%), SNP call rate, heterozygosity outliers, sex discordance, duplicate/relatedness checks, and Hardy–Weinberg equilibrium screening in controls.

      LEVEL 2

      Imputation

      Genotypes are phased and imputed to dense reference panels (TOPMed/HRC/1000 Genomes for human), expanding effective marker density to millions and enabling cross-cohort meta-analysis.

      LEVEL 2

      Association testing

      Linear/logistic regression with covariates for human traits; mixed linear models (GEMMA, GCTA, BOLT-LMM, SAIGE) correct for relatedness and structure; plant breeding uses GAPIT/TASSEL/FarmCPU with population structure (Q) and kinship (K) models.

      For study design: the decisions that determine whether the data answers your question.

      LEVEL 3

      Power and sample size

      GWAS power depends on allele frequency, effect size, and sample number. We run power calculations before you commit samples — underpowered GWAS produce false negatives and irreproducible hits.

      LEVEL 3

      The genome-wide significance threshold

      The conventional 5×10⁻⁸ threshold for human GWAS reflects ~1 million independent tests; species-specific thresholds depend on LD structure. QQ-plot inflation (genomic control λ) is monitored and reported.

      LEVEL 3

      Population structure in Indian cohorts

      India's population structure is complex and under-represented in reference panels. Our imputation-based Axiom module design enriches arrays for South Asian variation — a concrete advantage for Indian GWAS.

      LEVEL 3

      Post-GWAS analysis

      Significant loci are annotated (VEP), fine-mapped, and integrated with eQTL/functional data; candidate gene prioritisation and pathway enrichment complete the analysis.

      LEVEL 3

      Breeding programme integration

      For marker-assisted selection, we convert GWAS hits into low-density diagnostic marker sets — often via a second, small custom array — closing the loop from discovery to application.

      LEVEL 3

      Data submission

      GWAS summary statistics are formatted for GWAS Catalog/dbGaP/SRA submission where applicable.

      SNP
      single nucleotide polymorphism; a single-letter genetic variant.
      GWAS
      genome-wide association study.
      Imputation
      inferring untyped variants from typed neighbours using reference panels.
      LD (linkage disequilibrium)
      non-random association of variants; determines GWAS resolution.
      Kinship matrix
      the genetic relatedness matrix used in mixed-model association.
      PRS
      polygenic risk score; a weighted sum of risk alleles predicting trait liability.

      How it works, in two figures

      The Axiom myDesign system (1,500–2.6M markers, >>13M genotype-tested database markers, ~6-week design) is documented in Thermo Fisher technical materials; GWAS best practices (mixed models, QC thresholds, imputation) are established in the statistical genetics literature. See references below.

      Figure 1 Array vs sequencing economics. schematic
      Sequencing (discovery) Arrays (scale) Finds novel variants Higher cost per sample Complex analysis Fixed marker sets, >99% call rates Economical per sample at scale Custom design from your data
      Figure 1 | Array vs sequencing economics. (Illustrative schematic, not sample data.)
      Figure 2 GWAS workflow. schematic
      DNA Array hybridisation GeneTitan / iScan calling QC (call rate, HWE, sex) Imputation (TOPMed / HRC) Mixed-model GWAS & annotation
      Figure 2 | GWAS workflow. (Illustrative schematic, not sample data.)

      Built for the questions you are asking

      The platforms, pipelines and standards behind this service.

      Axiom GeneTitan instrument

      Fully automated imaging and calling for 96- or 384-sample plate formats — the throughput engine for large cohorts and breeding programmes.

      Axiom myDesign custom arrays

      From 1,500 markers (384HT, min. 1,920 samples) to 2.6 million markers (GW plates, min. 480 samples), designed from your SNP list with the Axiom Genomic Database's >more than 13 million genotype-tested markers.

      Illumina Infinium via partner lab

      Infinium Global Screening Array-24 v3.0 (654,027 fixed markers, up to 100K custom) and the GSA multi-disease booster, processed on the iScan by our partner laboratory — with QC and analysis by our team.

      Agrigenomics catalog arrays

      Established catalog arrays for major crops and livestock (e.g. bovine, porcine, ovine, chicken, maize, wheat, rice families) — marker counts and content vary by species; we match the array to your breeding or diversity question.

      Full GWAS pipeline

      QC → imputation (Beagle/Minimac; TOPMed/HRC/1000G for human) → population structure (PCA/ADMIXTURE) → association (mixed models: GEMMA, GCTA, BOLT-LMM, SAIGE for human; GAPIT, TASSEL, FarmCPU for plants) → annotation (VEP) → Manhattan/QQ visualisation.

      Polygenic risk scores

      PRS construction and validation from GWAS summary statistics where sample size supports it — with honest power caveats.

      What this service does and does not cover

      Scope note. Arrays type pre-selected markers only; variants absent from the array (and not recoverable by imputation) are not measured. Catalog array content varies by species and version — we confirm exact marker content for your project before ordering. Custom array design lead times and minimum sample orders are set by the manufacturer (Axiom: as few as 6 weeks after SNP lockdown; 384HT minimum 1,920 samples; GW plates minimum 480 samples). GWAS results are associations, not causal proof; functional validation is a separate step.

      Service highlights

      What you can expect from our team in Hyderabad.

      Axiom in-house, Illumina via partner

      Axiom arrays on our own GeneTitan MC, Illumina Infinium through a partner laboratory — the array is chosen for your project, not our inventory.

      Custom array development

      From 1,500 to 2.6M markers, designed from your data, with South Asian-optimised GWAS modules.

      Agrigenomics depth

      Catalog arrays and custom design for crops, livestock, and aquaculture species.

      Full GWAS analysis

      From raw calls to Manhattan plots and candidate genes — analysis included.

      Indian population expertise

      Imputation-based marker selection for South Asian cohorts.

      Breeding-to-discovery pipeline

      From diversity panels to diagnostic marker sets for selection programmes.

      Frequently asked, in plain language

      From the basics to the finer points of design and interpretation.

      basicHow many SNPs do I need for a GWAS?
      For human GWAS, arrays with ~300K–700K well-distributed markers, imputed to millions, are standard. For species with different LD structure, marker density requirements vary — we advise per species.
      basicWhich human array should I choose?
      For Indian and South Asian cohorts, the Axiom Asia PMRA or a custom myDesign array with Indian enrichment. For multi-ancestry biobanks, PangenomiX or PMDA; for pharmacogenomics, PangenomiX Plus; for large budget-sensitive GWAS, Illumina GSA. See the comparison table on this page — we confirm the choice with you before ordering.
      basicWhat sample do you need?
      Typically 50–200 ng DNA per sample at standard purity. We provide submission guidelines and QC every batch.
      basicWhich plant and animal arrays do you run?
      On our in-house GeneTitan MC we run Axiom agrigenomics arrays for rice, wheat, maize and groundnut; cattle (including Zebu breeds), buffalo, goat, sheep and chicken; and shrimp and tilapia — plus custom myDesign arrays for any species. Other Axiom catalog arrays are available on request.
      basicCan you design an array for my crop/livestock species?
      Yes — Axiom myDesign supports custom arrays for any organism with sequence data, from 1,500 to 2.6M markers.
      intermediateAxiom or Illumina — which platform?
      Axiom offers flexible custom design and high-throughput agrigenomics workflows; Illumina's GSA is the standard for human cohorts with strong imputation support. We recommend based on species, scale, and marker needs. Axiom arrays run in-house on our GeneTitan MC; Illumina arrays are processed by our partner laboratory.
      intermediateHow long does custom array design take?
      Axiom design typically completes in as few as 6 weeks after SNP lockdown. Minimum sample orders apply (1,920 samples for 384HT format; 480 for GW plates).
      intermediateWhat QC do you apply?
      Sample and SNP call rates, heterozygosity, sex concordance, duplicates/relatedness, and HWE screening — with all thresholds documented and reported.
      advancedCan you optimise an array for Indian populations?
      Yes — imputation-based SNP selection enriches the design with markers informative for South Asian variation, improving imputation accuracy and GWAS power for Indian cohorts.
      advancedWhich association models do you use?
      Human: GEMMA, GCTA, BOLT-LMM, SAIGE (binary traits with case–control imbalance). Plants: GAPIT, TASSEL, FarmCPU with Q+K models. Model choice is documented per project.
      advancedCan you build polygenic risk scores from my GWAS?
      Yes, where sample size and replication data support it — with honest power caveats and out-of-sample validation.
      advancedCan GWAS hits become breeding markers?
      Yes — we convert significant loci into low-density diagnostic marker sets, often via a small second custom array for routine selection screening.
      advancedAre these arrays for diagnostic use?
      The catalog arrays are labelled For Research Use Only by Thermo Fisher Scientific and Illumina. They are used for research, population and biobank studies; diagnostic use would need separate laboratory validation.

      Key literature & resources

      Selected sources behind the methods and reference values on this page. Figures labelled "schematic" or "illustrative" are generated for this page, not client data.

      1. Thermo Fisher Scientific. Axiom myDesign Genotyping Array solution — design guide and technical specifications (1,500–2.6M markers; 384HT and GW formats; Axiom Genomic Database). Thermo Fisher documentation, 2023–2025.
      2. Thermo Fisher Scientific. Axiom Analysis Suite and GeneTitan instrument documentation. Thermo Fisher, 2024.
      3. Illumina. Infinium Global Screening Array and Infinium iSelect product documentation. Illumina, 2023–2025.
      4. Yang J, et al. GCTA: a tool for genome-wide complex trait analysis. American Journal of Human Genetics. 2011;88(1):76–82.
      5. Loh PR, et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts (BOLT-LMM). Nature Genetics. 2015;47(3):284–290.
      6. Bradbury PJ, et al. TASSEL: software for association mapping of complex traits in diverse samples. Bioinformatics. 2007;23(19):2633–2635. (GAPIT: Lipka AE, et al. Bioinformatics. 2012;28(18):2397–2399. FarmCPU: Liu X, et al. PLoS Genetics. 2016;12(2):e1005767.)
      7. Zhou W, et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies (SAIGE). Nature Genetics. 2018;50(9):1335–1341.
      8. Das S, et al. Next-generation genotype imputation service and methods (Michigan Imputation Server; TOPMed/HRC panels). Nature Genetics. 2016;48(10):1284–1287.
      9. Thermo Fisher Scientific. Axiom PangenomiX and PangenomiX Plus arrays — data sheet and brochure.
      10. Thermo Fisher Scientific. Axiom Asia Precision Medicine Research Array, Precision Medicine Research Array, Precision Medicine Diversity Research Array and UK Biobank Axiom Array — product data sheets.
      11. Illumina. Infinium Global Screening Array-24 v3.0 — data sheet and product specifications.